NEW YORK (GenomeWeb) – Guardant Health has raised $50 million in a Series C financing round, the company said today.

The financing, which was led by Lightspeed Venture Partners, with Formation 8 and existing investors Khosla Ventures and Sequoia Capital participating, brings the company's total funding to date to just under $100 million. The company raised $30 million in a Series B round last April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.